Adam Feuerstein is an American blogger and columnist covering the biotechnology sector.

Education

Adam Feuerstein completed a bachelor's degree in political science at Emory University.

Career

Feuerstein covered business, technology, and commercial real estate for the '' San Francisco Business Times'' and the ''

Atlanta Business Chronicle The ''Atlanta Business Chronicle'' is a weekly newspaper covering business news in Atlanta, Georgia, published by American City Business Journals. The paper has both a weekly print edition and an online edition. History The ''Atlanta Business ...

'' as an assistant managing editor. He later wrote about business software for Upside.com. In March 2001, he joined

TheStreet.com ''TheStreet'' is a financial news and financial literacy website. It is a subsidiary of The Arena Group. The company provides both free content and subscription services such as Action Alerts Plus a stock recommendation portfolio co-managed by B ...

. From 2005 to 2006 he worked as a research analyst for a hedge fund before returning to TheStreet. He resigned in May 2017. Feuerstein accepted a position as a national biotechnology columnist at STAT in June 2017. Feuerstein is known for his style of reporting and his tweets to his large Twitter following. He often shares "unabashed" views on Biotech stock and the Food and Drug Administration.

References

{{DEFAULTSORT:Feuerstein, Adam Living people Year of birth missing (living people) American columnists Emory University alumni 20th-century American male writers 21st-century American male writers 21st-century American journalists 20th-century American journalists American male journalists American technology journalists American business and financial journalists American science journalists